This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals gain a deeper scientific understanding of recent advances in the diagnosis and management of HER2-positive and HER2-low breast cancer.
To claim CME credit for this course, please register at https://store.ascp.org/productlisting/productdetail?productId=123811419&_ga=2.269259641.929308495.1598834085-509862140.1542376895 Supported by an independent educational grant from Daiichi Sankyo, Inc.
0 Comments
The CMS Equity Plan for Improving Quality in Medicare outlines how the U.S. Centers for Medicare & Medicaid Services plans to advance health equity by improving the quality of care provided to minority and other underserved Medicare beneficiaries.
The framework for the plan consists of three interconnected domains: 1. Increasing understanding and awareness of disparities 2. Creating and sharing solutions 3. Accelerating implementation of effective actions In order to achieve complete equity, the framework and plan calls for continuous improvement and action—starting with the six priorities: Priority 1: Expand the Collection, Reporting, and Analysis of Standardized Data Priority 2: Evaluate Disparities Impacts and Integrate Equity Solutions Across CMS Programs Priority 3: Develop and Disseminate Promising Approaches to Reduce Health Disparities Priority 4: Increase the Ability of the Health Care Workforce to Meet the Needs of Vulnerable Populations Priority 5: Improve Communication and Language Access for Individuals with Limited English Proficiency and Persons with Disabilities Priority 6: Increase Physical Accessibility of Health Care Facilities 7 April 2020 is the day to celebrate the work of nurses and midwives and remind world leaders of the critical role they play in keeping the world healthy. Nurses and other health workers are at the forefront of COVID-19 response - providing high quality, respectful treatment and care, leading community dialogue to address fears and questions and, in some instances, collecting data for clinical studies. Quite simply, without nurses, there would be no response.
In this International Year of the Nurse and the Midwife, World Health Day will highlight the current status of nursing and around the world. WHO and its partners will make a series of recommendations to strengthen of the nursing and midwifery workforce. WHO has released the State of the World’s Nursing Report 2020 https://www.who.int/news-room/campaigns/world-health-day/world-health-day-2020 Immuno Oncology Virtual Cancer Committee To claim CME credit for this course, please register at:
https://store.ascp.org/productlisting/productdetail?productId=120806280 From "Crossing the Quality Chasm: A New Health System for the 21st Century" released in March 2001:
Six Aims for Improvement:
A health care system that achieves major gains in these six areas would be far better at meeting patient needs. Patients would experience care that is safer, more reliable, more responsive to their needs, more integrated, and more available, and they could count on receiving the full array of preventive, acute, and chronic services that are likely to prove beneficial. Clinicians and other health workers also would benefit through their increased satisfaction at being better able to do their jobs and thereby bring improved health, greater longevity, less pain and suffering, and increased personal productivity to those who receive their care. https://www.ncbi.nlm.nih.gov/books/NBK222265/ The rapid rate of breakthroughs in immuno-oncology (IO) continues to disrupt diagnostic processes and workflows in cancer care. As more patients with different types of cancers are treated with immune checkpoint inhibitor therapy, pathologists and laboratory professionals need to work closely with oncologists and other cancer clinicians to optimize IO biomarker testing and ensure that patients are treated with the right agents. This live 1.5-hour CME multidisciplinary, interactive panel discussion will highlight practical ways to overcome barriers around IO biomarker testing, communication among members of the multidisciplinary cancer care team, and the use of immune checkpoint inhibitor therapy to improve patient care. WHO calls for urgent action to reduce patient harm in healthcare. 13 September 2019: Millions of patients are harmed each year due to unsafe health care worldwide resulting in 2.6 million deaths annually in low-and middle-income countries alone. Most of these deaths are avoidable. The personal, social and economic impact of patient harm leads to losses of trillions of US dollars worldwide. The World Health Organization is focusing global attention on the issue of patient safety and launching a campaign in solidarity with patients on the very first World Patient Safety Day on 17 September. On the very first World Patient Safety Day WHO is prioritizing patient safety as a global health priority and urging patients, healthcare workers, policy makers and health care industry to “Speak up for patient safety!”.
17 September was established as World Patient Safety Day by the 72nd World Health Assembly in May 2019. More information about WHO’s campaign can be accessed at https://www.who.int/campaigns/world-patient-safety-day/2019
This 1.5 hour online CME/CMLE multidisciplinary panel discussion will discuss how to apply the latest science and evidence as you navigate administrative challenges surrounding institutional policies and procedures. You will gain a deeper understanding that surrounds the complexity of PD-L1 testing based on the type of tumor, different antibody assays, and scoring systems. Additionally, you will learn about the practical application of MSI/MMR testing and the potentially emerging role of tumor mutational burden (TMB) when treating patients with checkpoint inhibitor therapy.
To claim CME credit for this course, please register at:
https://store.ascp.org/productlisting/productdetail?productId=104769493 Here are two educational activities that highlight the implementation of I-O education in the community:
Implementing Immuno-Oncology Education in a Community Cancer Center Funded by an independent educational grant from Bristol-Myers Squibb. Overcoming Common Barriers Around the Application of Immuno-Oncology in Community Settings Funded by an independent educational grant from Pfizer/Merck KGaA. These CME activities are hosted on ASCP.org
This CME activity is provided by the American Society for Clinical Pathology (ASCP):
Update on Immuno-Oncology Biomarkers
This 1 hour, interactive, online CME/CMLE module will help pathologists, laboratory professionals, and other members of the cancer care team gain deeper scientific knowledge in immuno-oncology (IO) and keep up with the rapidly evolving science of IO biomarkers including IO biomarker testing, tumor mutational burden, PD-L1 testing and interpretation, and the use of checkpoint inhibitors for treatment.
|
Author@DrJosephKim Sign up to receive updates:
|